Biolargo Stock Today
| BLGO Stock | USD 0.25 0.01 3.85% |
Performance6 of 100
| Odds Of DistressLess than 10
|
BioLargo is selling at 0.25 as of the 1st of February 2025; that is 3.85 percent decrease since the beginning of the trading day. The stock's open price was 0.26. BioLargo has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 7th of May 2024 and ending today, the 1st of February 2025. Click here to learn more.
BioLargo, Inc. invents, develops, and commercializes various platform technologies. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California. Biolargo operates under Chemicals classification in the United States and is traded on OTC Exchange. The company has 275.42 M outstanding shares. More on BioLargo
Moving against BioLargo OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioLargo OTC Stock Highlights
| Chairman, CEO and Pres | Dennis Calvert |
| Business Concentration | Materials, Chemicals, Chemicals, Basic Materials (View all Sectors) |
BioLargo [BLGO] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 64.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioLargo's market, we take the total number of its shares issued and multiply it by BioLargo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioLargo conducts business under Chemicals sector and is part of Materials industry. The entity has 275.42 M outstanding shares.
BioLargo currently holds about 1.23 M in cash with (3.94 M) of positive cash flow from operations.
Check BioLargo Probability Of Bankruptcy
Ownership AllocationBioLargo holds a total of 275.42 Million outstanding shares. BioLargo shows 14.7 percent of its outstanding shares held by insiders and 0.04 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioLargo Ownership Details
BioLargo Risk Profiles
| Mean Deviation | 3.42 | |||
| Semi Deviation | 3.55 | |||
| Standard Deviation | 5.42 | |||
| Variance | 29.41 |
BioLargo Stock Against Markets
Picking the right benchmark for BioLargo otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioLargo otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioLargo is critical whether you are bullish or bearish towards BioLargo at a given time. Please also check how BioLargo's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioLargo without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
BioLargo Corporate Management
Elected by the shareholders, the BioLargo's board of directors comprises two types of representatives: BioLargo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLargo. The board's role is to monitor BioLargo's management team and ensure that shareholders' interests are well served. BioLargo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLargo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Smith | Pres Water | Profile | |
| Randall Moore | Science Engineering | Profile | |
| Steven II | Pres Inc | Profile | |
| CFA II | Chief Officer | Profile |
Other Information on Investing in BioLargo OTC Stock
BioLargo financial ratios help investors to determine whether BioLargo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLargo with respect to the benefits of owning BioLargo security.